Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review

BACKGROUND: An accurate and comprehensive assessment of harms is a fundamental part of an accurate weighing of benefits and harms of an intervention when making treatment decisions; however, harms are known to be underreported in journal publications. Therefore, we sought to compare the completeness...

Descripción completa

Detalles Bibliográficos
Autores principales: Paludan-Müller, Asger S., Créquit, Perrine, Boutron, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028762/
https://www.ncbi.nlm.nih.gov/pubmed/33827569
http://dx.doi.org/10.1186/s12916-021-01955-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028762/
https://www.ncbi.nlm.nih.gov/pubmed/33827569
http://dx.doi.org/10.1186/s12916-021-01955-0

Ejemplares similares